earnings digest brief roche holding ag revenue rises only amid lower sales of tamiflu swiss pharmaceutical company roche holding ag posted a lower than forecast increase in third quarter revenue amid a sales drop in its influenza drug tamiflu roche said overall sales rose to billion swiss francs &# billion from billion francs a year earlier it didnt disclose third quarter earnings shares fell to francs in zurich sales of tamiflu fell to million francs roche has repeatedly signaled that governments and companies would complete their stockpiling in the third quarter tamiflu sales rose sharply during the past few quarters as governments and companies bought the drug in preparation for a potential outbreak of a bird flu pandemic 
